IDIA — Idorsia Share News
0.000.00%
Last trade - 00:00- CH₣1.13bn
- CH₣2.28bn
- CH₣220.58m
Brief: Idorsia FY EBIT CHF -33 Million
Brief: Idorsia Announces Exclusive License And Supply Agreement With Ems S.A.
Swiss stocks - Factors to watch on January 6
Brief: Idorsia Posts Phase 3 Study Results Of Daridorexant
Brief: Idorsia’S Jeraygo (Aprocitentan) Approved In Canada For The Treatment Of Resistant Hypertension
Brief: Idorsia-New Hypertension Publication Underscores Aprocitentan’S Potential In Managing Hypertension Patients With Ckd
Europe Research Roundup: BMW, EQT, Nestle
Swiss stocks - Factors to watch on October 30
Brief: Idorsia 9M EBIT CHF 23 Million
Brief: Idorsia Completes Upsized Offering Of Shares
Swiss stocks - Factors to watch on October 10
Brief: Idorsia Primary ABB Orders Below CHF 4.00 Risk Missing, Says Bookrunner
Brief: Bookrunner Says Idorsia Primary ABB Books Are Closed
Brief: Bookrunner Says Idorsia Primary ABB Books Covered
Brief: Idorsia Launches An Offering Of Registered Shares
Swiss stocks - Factors to watch on October 8
Brief: Idorsia’S Jeraygo Approved In Switzerland For The Treatment Of Resistant Hypertension
Brief: Idorsia To Collaborate With Two Leading Academic Medical Centers To Launch Impact-Htn - A Us Initiative To Transform Care For Patients With Difficult-To-Control Hypertension
Europe Research Roundup: BMW, Fugro, Mercedes-Benz